KZIA
Kazia Therapeutics·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
KZIA Filings
Filing Date
Form Description
Form Type
2025-12-02
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-12-02 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-18
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-18 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-18
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-18 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-18
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-18 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-11-18
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Key Events
2025-11-18 · Key Events
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
2025-11-14
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-14 ·
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2025-11-07
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
Financials
2025-11-07 · Financials
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025-10-31
Form NT 20-F - Notification of inability to timely file Form 20-F
2025-10-31 ·
Form NT 20-F - Notification of inability to timely file Form 20-F
2025-10-07
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-10-07 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-10-07
Form 424B3 - Prospectus [Rule 424(b)(3)]
2025-10-07 ·
Form 424B3 - Prospectus [Rule 424(b)(3)]
